Plasma Lipid Profile and Incident Ischemic Stroke The Atherosclerosis Risk in Communities (ARIC) Study

作者: Eyal Shahar , Lloyd E. Chambless , Wayne D. Rosamond , Lori L. Boland , Christie M. Ballantyne

DOI: 10.1161/01.STR.0000057812.51734.FF

关键词:

摘要: Background and Purpose— The role of circulating lipids lipoproteins in the pathogenesis ischemic stroke remains uncertain despite 3 decades research. We examined this issue a large population-based cohort. Methods— Between 1987 1989, 14 175 middle-aged men women, free clinical cardiovascular disease, took part first examination Atherosclerosis Risk Communities (ARIC) study Baseline measurements included plasma levels LDL cholesterol, HDL apolipoprotein B, A-1, triglycerides myriad risk factors for disease. cohort was followed disease end points. Results— Over an average follow-up 10 years (142 704 person-years at risk), we documented 305 participants (161 144 women). After multivariable adjustment factors, categorical spline regression analyses entire sample, as well sample alone, revealed weak inco...

参考文章(81)
Philip A. Wolf, Epidemiology of Stroke Stroke. ,vol. 16, pp. 13- 34 ,(2004) , 10.1016/B0-44-306600-0/50005-5
G. Russell Warnick, Cathy Mayfield, Joan Benderson, Jung-Shou Chen, John J. Albers, HDL Cholesterol Quantitation by Phosphotungstate-Mg2+ and by Dextran Sulfate-Mn2+-Polyethylene Glycol Precipitation, Both with Enzymic Cholesterol Assay Compared with the Lipid Research Method American Journal of Clinical Pathology. ,vol. 78, pp. 718- 723 ,(1982) , 10.1093/AJCP/78.5.718
Mark L. Dyken, Stroke Risk Factors Springer, New York, NY. pp. 83- 101 ,(1991) , 10.1007/978-1-4757-4226-8_6
S A Brown, D F Epps, J K Dunn, A R Sharrett, J R Patsch, A M Gotto, W Patsch, Effect of Blood Collection and Processing on Radioimmunoassay Results for Apolipoprotein B in Plasma Clinical Chemistry. ,vol. 36, pp. 1662- 1666 ,(1988) , 10.1093/CLINCHEM/36.9.1662
C. J. Johnson, S. J. Kittner, R. J. McCarter, M. A. Sloan, B. J. Stern, D. Buchholz, T. R. Price, Interrater Reliability of an Etiologic Classification of Ischemic Stroke Stroke. ,vol. 26, pp. 46- 51 ,(1995) , 10.1161/01.STR.26.1.46
PATRICIA R. HEBERT, J. MICHAEL GAZIANO, KI SAU CHAN, CHARLES H. HENNEKENS, Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality: An Overview of Randomized Trials Survey of Anesthesiology. ,vol. 42, ,(1998) , 10.1097/00132586-199806000-00060
Gerard J Blauw, A Margot Lagaay, Rudi GJ Westendorp, STATINS FOR PREVENTION OF STROKE The Lancet. ,vol. 352, pp. 144- 145 ,(1998) , 10.1016/S0140-6736(98)85049-6